Skip to main content
. 2021 Sep 16;33(11):2174–2188.e5. doi: 10.1016/j.cmet.2021.09.009

Table 2.

Characteristics of adult Medical ICU patients over a 5-year period between 2013 and 2019



ARDS

Characteristic Overall, n = 4,748a No, n = 3,558a Yes, n = 1,190a p valueb
Age 68 (55, 78) 67 (53, 78) 71 (59, 79) <0.001
Female 2,269 (47.8%) 1,758 (49.4%) 511 (42.9%) <0.001
Race 0.6
 White 2,175 (45.8%) 1,637 (46.0%) 538 (45.2%)
 Black 544 (11.5%) 416 (11.7%) 128 (10.8%)
 Asian 373 (7.9%) 272 (7.6%) 101 (8.5%)
 Unspecified/other 1,656 (34.9%) 1,233 (34.7%) 423 (35.5%)

Comorbidities

Obesity 1,172 (24.7%) 845 (23.7%) 327 (27.5%) 0.010
COPD 1,040 (21.9%) 701 (19.7%) 339 (28.5%) <0.001
Kidney disease 1,079 (22.7%) 736 (20.7%) 343 (28.8%) <0.001
CHF 1,029 (21.7%) 684 (19.2%) 345 (29.0%) <0.001
Arrhythmia 2,064 (43.5%) 1,425 (40.1%) 639 (53.7%) <0.001
Diabetes 1,143 (24.1%) 874 (24.6%) 269 (22.6%) 0.2
Hypertension 2,273 (47.9%) 1,667 (46.9%) 606 (50.9%) 0.015
Liver disease 830 (17.5%) 578 (16.2%) 252 (21.2%) <0.001
Malignancy 846 (17.8%) 621 (17.5%) 225 (18.9%) 0.3

Acute diagnoses

Pneumonia 1,571 (33.1%) 878 (24.7%) 693 (58.2%) <0.001
Sepsis 2,699 (56.8%) 1,509 (42.4%) 1,190 (100.0%) <0.001
Septic shock 657 (13.8%) 229 (6.4%) 428 (36.0%) <0.001

Laboratory values

Peak glucose (Mg/dL) 214 (159, 322) 197 (149, 303) 254 (197, 358) <0.001
Peak lactate (MEq/L)c 1.9 (1.1, 4.0) 1.8 (1.1, 3.9) 2.1 (1.2, 4.5) <0.001
Peak creatinine (Mg/dL)c 1.33 (0.80, 2.58) 1.19 (0.77, 2.31) 1.72 (1.03, 3.15) <0.001
Peak WBC (U/L)c 12 (7, 19) 11 (7, 17) 15 (9, 22) <0.001

Conditions

Hyperglycemia 3,256 (68.6%) 2,230 (62.7%) 1,026 (86.2%) <0.001
Leukopenia 827 (17.4%) 587 (16.5%) 240 (20.2%) 0.004
Leukocytosis 2,460 (51.8%) 1,693 (47.6%) 767 (64.5%) <0.001
Anemia 3,677 (77.4%) 2,676 (75.2%) 1,001 (84.1%) <0.001
Thrombocytopenia 2,442 (51.4%) 1,727 (48.5%) 715 (60.1%) <0.001
Hypothermia 303 (6.4%) 182 (5.1%) 121 (10.2%) <0.001
Fever 1,375 (29.0%) 885 (24.9%) 490 (41.2%) <0.001

Outcomes

Vasopressor requirement 1,929 (40.6%) 1,133 (31.8%) 796 (66.9%) <0.001
Non-invasive mechanical ventilation 493 (10.4%) 298 (8.4%) 195 (16.4%) <0.001
Intubation 1,881 (39.6%) 886 (24.9%) 995 (83.6%) <0.001
Intubation and HG <0.001
 Intubation HG− 354 (18.8%) 231 (26.1%) 123 (12.4%)
 Intubation HG+ 1,527 (81.2%) 655 (73.9%) 872 (87.6%)
In-hospital mortality 1,094 (23.0%) 649 (18.2%) 445 (37.4%) <0.001
Mortality and HG <0.001
 Mortality HG− 177 (16.2%) 141 (21.7%) 36 (8.1%)
 Mortality HG+ 917 (83.8%) 508 (78.3%) 409 (91.9%)
ICU stay (days) 4 (3, 8) 4 (2, 6) 9 (5, 14) <0.001
Hospital stay (days) 11 (6, 22) 9 (5, 18) 18 (10, 31) <0.001
Hospital stay HG− (days) 8 (4, 15) 7 (4, 14) 14 (7, 22) <0.001
Hospital stay Hg+ (days) 14 (7, 25) 11 (5, 22) 19 (11, 32) <0.001
a

Median (IQR) or frequency (%).

b

Statistical tests performed to assess association between patient characteristic and ARDS: Wilcoxon rank-sum test on continuous variables (age, laboratory values, ICU, and hospital stay); chi-square test of independence on categorical variables (all other characteristics).

c

Number of patients with missing values: peak lactate 1365; peak creatinine 109; peak WBC 129.